Fidaxomicin versus Vancomycin for <i>Clostridium difficile</i> Infection

Louie, Thomas; A. Miller, Mark; M. Mullane, Kathleen; Heinz Weiss, Karl; Lentnek, Arnold; Golan, Yoav; L. Gorbach, Sherwood; Sears, P.S.; Shue, Youe‐Kong

doi:10.1056/nejmoa0910812

Public

Fidaxomicin versus Vancomycin for Clostridium difficile Infection

Published in New England Journal of Medicine • Feb 2, 2011

Authors:

Thomas Louie

Mark A. Miller

Kathleen M. Mullane

Abstract

BACKGROUND: Clostridium difficile infection is a serious diarrheal illness associated with substantial morbidity and mortality. Patients generally have a response to oral vancomycin or metronidazole; however, the rate of recurrence is high. This phase 3 clinical trial compared the efficacy and safet...

Subject

Fidaxomicin

Medicine

Vancomycin

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!